AvantorFRA:AVG +2.63%59 Market Cap is €6,178 Mil as of Jun. 28, 2026. GuruFocus rates FRA:AVG with a GF Score™ of 59/100 and a GF Value™ of €15.56 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Avantor ranks better than 94.69% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avantor's share price for the quarter that ended in Mar. 2026 was €6.55. Avantor's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 683 Mil. Therefore, Avantor's market cap for the quarter that ended in Mar. 2026 was €4,473 Mil.
Avantor's quarterly market cap
declined
from Sep. 2025 (€6,751 Mil) to Dec. 2025 (€6,479 Mil) and
declined
from Dec. 2025 (€6,479 Mil) to Mar. 2026 (€4,473 Mil).
Avantor's annual market cap
declined
from Dec. 2023 (€14,039 Mil) to Dec. 2024 (€13,616 Mil) and
declined
from Dec. 2024 (€13,616 Mil) to Dec. 2025 (€6,479 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avantor's Enterprise Value for Today is €9,291 Mil.
Avantor (FRA:AVG) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avantor Market Cap Related Terms
Avantor Market Cap Historical Data
* Premium members only.
The historical data trend for Avantor's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Avantor's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avantor Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avantor's Market Cap distribution charts can be found below:
* The bar in red indicates where Avantor's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avantor's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (FRA:AVG) has a Market Cap of €6,178 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avantor and its competitors. According to the industry distribution chart, Avantor ranks #46 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 5.3%.
Is Avantor's Market Cap too high?
Avantor's current Market Cap is €6,178 Mil. Based on the distribution chart, Avantor ranks #46 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Avantor has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avantor's Market Cap compare to TFX and RGEN?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #46 out of 866 companies for Market Cap. This places Avantor in the top 5% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current Market Cap is €6,178 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Based on GuruFocus' analysis, Avantor (FRA:AVG) is currently considered Possible Value Trap. The stock's GF Value™ is €15.56, compared to a current price of €8.67 — trading 44.3% below its estimated fair value. The current Market Cap is €6,178 Mil. Avantor's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Avantor (FRA:AVG), the current Market Cap is €6,178 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (FRA:AVG) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of €8.67 is trading 44.3% below its estimated GF Value™ of €15.56.
GuruFocus considers Avantor to be Possible Value Trap.
Key valuation signals for FRA:AVG:
Market Cap: €6,178 Mil
GF Value™: €15.56 vs. price of €8.67 (44.3% below fair value)
No single metric tells the full story. See the FRA:AVG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
59GF Score
Get the complete analysis for FRA:AVG
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AVG has been successfully added to your 
